Degradation of the extracellular matrix (ECM) is a critical feature of cancer cell invasion. Accumulating evidence suggests that proteolytic enzymes, including the matrix metalloproteinase (MMP) family, contribute to these multifactorial processes. Important features of these enzymes that exist in normal and neoplastic invasive processes are the induction of proteinase expression and the regulation of proteolytic activity. A common feature of the enzymes cited above is that they are produced as zymogens and require an activation step to become catalytically active. In addition, the expression of these enzymes requires stimuli that induce at the level of transcription whereas others are transcriptionally overexpressed. A correlation between proteolysis and malignant progression has been established. Specific inhibitors of serine and metalloproteinases have been used in in vitro and in vivo modelsI4 to demonstrate inhibition of tumor cell invasion and metastasis. The exact role of these specific proteinases in the mechanisms involved in the formation of metastatic lesions remains unclear.The interaction of tumor cells with the ECM and basement membrane occurs at multiple stages in the metastatic cascade. Benign adenoma and in situ carcinomas are characterized by a continuous basement membrane that separates the epithelium from the underlying stroma, whereas invasive carcinomas demonstrate zones of basement membrane loss around the invading tumor cells. Attention has been focused on proteolytic enzymes whose substrate specificities include ECM and basement membrane components. Some enzymes that have been implicated in the invasive processes of cancer cells include the MMPsS and urokinase-type plasminogen activator (uPA).~ Natural inhibitors of these enzymes have been identified and include the tissue inhibitors of metalloproteinases-1 and -2 (TIMP-1 and TIMP-2)7-9 and plasminogen activator inhibitor types-1 and -2 (PAI-1 and PAI-2).1°Positive correlations between the expression of MMPs and uPA and the malignant phenotype have been demonstrated in vitro using numerous tumor and transformed cell liness4 These correlative studies have been supported by analyses using specific inhibitors. Inhibitors of MMPs or uPA have been shown to block tumor cell invasion across native or reconstituted basement membranes in v i t r~.~J *~'~ The ability of TIMP to prevent matrix degradation has been demonstrated in cell model systems. Inhibition of tumor cell invasion and metastasis in an in vivo animal model has been demonstrated using anti-uPA antibodiesZ or in vivo injections of TIMP.I3 A causal role for MMPs in cancer cell invasion was demonstrated using antisense TIMP RNA.14 These studies demonstrated that a reduction in TIMP levels resulted in a change of the cellular phenotype to one that was invasive in an in vitro model and metastatic in an in vivo model. These analyses implicate the MMPs in cancer cell invasion.The MMPs represent a family of structurally related enzymes that are grouped 324
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.